Back to User profile » Professor Sanjay Popat

Papers published by Professor Sanjay Popat:

Expert Opinion

Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

Ou SI, Le X, Nagasaka M, Reungwetwattana T, Ahn MJ, Lim DW, Santos ES, Shum E, Lau SC, Lee JB, Calles A, Wu F, Lopes G, Sriuranpong V, Tanizaki J, Horinouchi H, Garassino MC, Popat S, Besse B, Rosell R, Soo RA

Lung Cancer: Targets and Therapy 2024, 15:87-114

Published Date: 22 June 2024

Review

Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions

O'Sullivan HM, Feber A, Popat S

OncoTargets and Therapy 2023, 16:249-259

Published Date: 7 April 2023

Original Research

Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies

Miura S, Jung HA, Lee SY, Lee SH, Lee MK, Lee YC, Hochmair MJ, Yang CT, Märten A, Yang JCH, Popat S

OncoTargets and Therapy 2022, 15:873-882

Published Date: 22 August 2022

Review

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer

Yap TA, Popat S

Pharmacogenomics and Personalized Medicine 2014, 7:285-295

Published Date: 19 September 2014